Publications by authors named "Facundo Bertera"

Claim this Profile
E
Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses.
Sofía Maldonado, Pedro Fuentes, Ezequiel Bernabeu, Facundo Bertera, Javier Opezzo

Pharmaceutics· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic monitoring of itraconazole in patients with chronic pulmonary aspergillosis: a possible solution to a frequent problem].
Florencia Capaccioli, Fernando Messina, Gabriela Santiso, Emmanuel Marin, Mercedes Romero, Facundo Bertera

Medicina (B Aires)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual strategy to improve the oral bioavailability of efavirenz employing nanomicelles and curcumin as a bio-enhancer.
Pedro Fuentes, Ezequiel Bernabeu, Facundo Bertera, Mariana Garces, Javier Oppezzo

Int J Pharm· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningeal cryptococcosis and SARS-CoV-2 infection in people living with HIV/AIDS.
Fernando Antonio Messina, Andrés Benchetrit, Andrea Bocassi, María de Las Mercedes Romero, Sofía Bauer, Facundo Bertera

Biomedica· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.
Julieta S Del Mauro, Paula D Prince, Yanina Santander Plantamura, Miguel A Allo, Luciano Parola, Facundo M Bertera

Hypertens Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
Julieta S Del Mauro, Paula D Prince, Miguel A Allo, Yanina Santander Plantamura, Marcela A Morettón, Facundo M Bertera

J Hypertens· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response.
Christian Höcht, Facundo M Bertera, Yanina Santander Plantamura, Luciano Parola, Julieta S Del Mauro

Expert Opin Drug Metab Toxicol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the Real Efficacy of Beta-Blockers for the Treatment of Essential Hypertension?
Christian Hocht, Facundo M Bertera, Julieta S Del Mauro, Yanina Santander Plantamura, Carlos A Taira

Curr Pharm Des· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluation.
Marcel Wegmann, Luciano Parola, Facundo M Bertera, Carlos A Taira, Maximiliano Cagel

J Pharm Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in therapy for the prevention of HIV transmission from mother to child.
Marcela A Moretton, Facundo Bertera, Eduardo Lagomarsino, Jennifer Riedel, Diego A Chiappetta

Expert Opin Pharmacother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.
Julieta S Del Mauro, Paula D Prince, Martín Donato, Nahuel Fernandez Machulsky, Marcela A Morettón, Facundo M Bertera

J Am Soc Hypertens· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drugs affecting blood pressure variability: an update.
Christian Hocht, Julieta Sofia Del Mauro, Facundo Martín Bertera, Carlos Alberto Taira

Curr Pharm Des· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Models for evaluating the pharmacokinetics and pharmacodynamics for β-blockers.
Christian Höcht, Facundo Martín Bertera, Julieta Sofía Del Mauro, Carlos Alberto Taira

Expert Opin Drug Metab Toxicol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats.
Facundo Martín Bertera, Julieta Sofía Del Mauro, Valeria Lovera, Diego Chiappetta, Ariel Héctor Polizio

Hypertens Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats.
Facundo Martín Bertera, Julieta Sofía Del Mauro, Valeria Lovera, Diego Chiappetta, Ariel Héctor Polizio

Hypertens Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats.
Facundo Martín Bertera, Julieta Sofía Del Mauro, Ariel Héctor Polizio, Diego Chiappetta, Carlos Alberto Taira

Naunyn Schmiedebergs Arch Pharmacol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability.
Facundo Martín Bertera, Julieta Sofía Del Mauro, Diego Chiappetta, Ariel Héctor Polizio, Fabián Buontempo

Naunyn Schmiedebergs Arch Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.
Facundo Bertera, Carla Andrea Di Verniero, Marcos Alejandro Mayer, Diego Chiappetta, Fabián Buontempo

Xenobiotica· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heme oxygenase-1 overexpression fails to attenuate hypertension when the nitric oxide synthase system is not fully operative.
Ariel H Polizio, Diego M Santa-Cruz, Karina B Balestrasse, Mariela M Gironacci, Facundo M Bertera

Pharmacology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of blood pressure variability in the assessment of cardiovascular risk and benefits of antihypertensive therapy.
Christian Höcht, Facundo Martín Bertera, Carlos Alberto Taira

Expert Rev Clin Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.
Carla Andrea Di Verniero, Facundo Bertera, Fabián Buontempo, Ezequiel Bernabeu, Diego Chiappetta

J Pharm Pharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.
Christian Höcht, Facundo Martín Bertera, Marcos Alejandro Mayer, Carlos Alberto Taira

Expert Opin Drug Metab Toxicol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is urethane-chloralose anaesthesia appropriate for pharmacokinetic-pharmacodynamic assessment? Studies with carvedilol.
Facundo Martín Bertera, Carla Andrea Di Verniero, Marcos Alejandro Mayer, Guillermo Federico Bramuglia, Carlos Alberto Taira

J Pharmacol Toxicol Methods· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension.
Facundo M Bertera, Marcos A Mayer, Javier A W Opezzo, Carlos A Taira, Christian Höcht

J Pharm Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension.
Facundo M Bertera, Marcos A Mayer, Javier A W Opezzo, Carlos A Taira, Christian Höcht

J Pharmacol Toxicol Methods· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis